Can I Cancel at Any Time? | Calibrate Weight-Loss Program Explained

What Is Calibrate's Cancellation Policy?

Calibrate is structured as a year-long metabolic health program, not a month-to-month service. Members sign an annual agreement at enrollment. Cancellation is technically possible at any point, but whether you receive a full or partial refund depends on when you cancel and what services you have already used.

The program bundles physician visits, health coaching, GLP-1 medication coordination, and lab work into a single fee. Because physicians and coaches begin delivering services from day one, Calibrate's terms historically limit full refunds to a short window after enrollment, often 30 days or fewer, before services have been substantially rendered.

What the Contract Actually Says

Calibrate's member agreement specifies that after the refund window closes, members may still cancel future services but forfeit fees already paid for the current term. This is common in subscription healthcare: the American Medical Association's policy on prepaid health plans notes that services rendered prior to cancellation are generally non-refundable once rendered by a licensed clinician. Always read your individual agreement at the time of enrollment, because terms can change.

How to Submit a Cancellation Request

Most members cancel through the Calibrate member portal or by contacting member support directly via email. Verbal cancellations are rarely honored as binding. Send a written request, keep a timestamped copy, and request written confirmation of cancellation and any refund amount. If Calibrate does not confirm within 5 to 7 business days, follow up in writing a second time before escalating.

Refunds and Chargebacks

If you believe you qualify for a refund under Calibrate's terms and are refused, you may dispute the charge with your credit card issuer. Be aware that chargebacks initiated outside of a legitimate dispute window, or without documented attempts to resolve with the merchant first, can result in collections action or account closure. The Consumer Financial Protection Bureau maintains guidance on credit card dispute rights at consumerfinance.gov.

Why the Cancellation Decision Is Also a Medical Decision

This is where most "cancel Calibrate" articles stop. They treat cancellation as a billing question. It is also a clinical question, because most Calibrate members are taking a GLP-1 receptor agonist, typically semaglutide (Ozempic, Wegovy) or liraglutide (Saxenda).

Stopping a GLP-1 abruptly is not like canceling a gym membership. The drug is doing active metabolic work. Removing it without a plan causes predictable, documented weight regain.

The STEP 1 Extension: What Happens When You Stop Semaglutide

The STEP 1 trial (N=1,961) demonstrated that semaglutide 2.4 mg produced 14.9% mean body weight loss at 68 weeks versus 2.4% with placebo [1]. The extension phase, published in the New England Journal of Medicine in 2022, followed participants for one year after stopping the drug. At the end of that year, the semaglutide group had regained a mean of 11.6 percentage points of body weight, recovering approximately two-thirds of what they had lost [2]. Cardiometabolic improvements, including reductions in blood pressure and waist circumference, also reversed substantially.

That number is not a scare tactic. It is a direct consequence of GLP-1's mechanism: the drug suppresses appetite via hypothalamic GLP-1 receptors and slows gastric emptying. Remove the drug, and those signals return to baseline [3].

What the Endocrine Society Says About Discontinuation

The Endocrine Society's 2023 Clinical Practice Guideline on obesity pharmacotherapy states that GLP-1 receptor agonists should be considered long-term or indefinite therapy for most patients with obesity, given the chronic nature of the condition and the documented weight regain after cessation [4]. The guideline reads:

"Clinicians should counsel patients that anti-obesity medications generally need to be continued long term, as weight regain typically occurs after discontinuation, similar to what happens with medications for other chronic diseases such as hypertension or diabetes."

This framing, obesity as a chronic disease requiring ongoing medical management, is the clinical reason telehealth programs like Calibrate exist. Canceling the program without transitioning care may leave you without a prescribing physician, which means losing access to the medication itself.

Blood Sugar and Cardiovascular Considerations

For members who are also managing type 2 diabetes or prediabetes, semaglutide carries additional considerations beyond weight. The SUSTAIN-6 trial (N=3,297) showed a 26% relative risk reduction in major adverse cardiovascular events with semaglutide 0.5 mg or 1 mg versus placebo in patients with type 2 diabetes and high cardiovascular risk [5]. Stopping the drug without a transition plan could affect glycemic control. Talk to a physician before stopping, not after.

Alternatives to Outright Cancellation

Before canceling, ask whether any of these options fit your situation better.

Pause or Deferral

Some membership-based telehealth programs offer a pause option for financial hardship or medical reasons. Contact Calibrate member support and ask specifically whether a deferral exists. Get the answer in writing.

Medication-Only Transfer

Your GLP-1 prescription belongs to you, not to Calibrate. A licensed prescriber at Calibrate or any other licensed physician can transfer or re-prescribe your current medication. HealthRX, for example, offers GLP-1 prescribing services that include physician oversight without the full-program cost structure. Before canceling, ask your Calibrate physician to write a 90-day supply or to transfer care to another provider.

Dose Reduction

If cost is the primary driver, discuss a dose reduction with your Calibrate physician. Semaglutide at lower maintenance doses, such as 0.5 mg or 1 mg weekly, costs less than 2.4 mg weekly and may be sufficient to maintain a meaningful portion of weight lost. The STEP 5 trial (N=304) showed 15.2% weight loss at 104 weeks with semaglutide 2.4 mg, but clinically meaningful weight maintenance was observed at lower doses in some patients as well [6].

Insurance-Covered Alternatives

If Wegovy coverage is driving your cost, verify your benefits directly with your insurer rather than through Calibrate. The FDA approved Wegovy (semaglutide 2.4 mg) for chronic weight management in June 2021 [7]. Many commercial plans now cover it with prior authorization. CMS coverage for GLP-1s in obesity (without diabetes) remains limited under traditional Medicare as of early 2025, but state Medicaid programs vary [8].

What to Do Clinically Before You Cancel

Follow this sequence to protect your health outcomes when leaving any GLP-1-based program.

Step 1: Get Your Records

Request a complete copy of your medical records from Calibrate before canceling. Under HIPAA, you are entitled to your records within 30 days of request [9]. This includes your lab results, physician notes, and medication history. You will need these for any new provider.

Step 2: Arrange Transition Care

Book an appointment with a new prescribing physician before your last Calibrate visit. A gap in care, even two to four weeks without medical oversight during a dose adjustment, creates unnecessary risk. The FDA's Risk Evaluation and Mitigation Strategy (REMS) for certain anti-obesity medications requires prescriber enrollment and patient counseling [10]. Confirm your new provider is enrolled appropriately.

Step 3: Discuss a Taper

Abrupt discontinuation is rarely necessary. Semaglutide has a half-life of approximately one week, so physiological withdrawal is not a concern the way it is with some other drug classes. The issue is behavioral and metabolic rebound, not pharmacological dependence. Your physician may recommend staying at your current dose for 4 to 8 additional weeks while you establish new habits, then stepping down if medication access is the limiting factor.

Step 4: Set a Weight Monitoring Plan

Weigh yourself weekly after stopping. The STEP 1 extension data showed that weight regain begins within weeks of discontinuation, not months [2]. Early detection gives you the option to restart medication before regaining 5% or more of body weight, the threshold at which restarting semaglutide typically requires re-titration from the lowest dose.

Step 5: Address the Underlying Trigger

Ask yourself honestly why you are canceling. Cost, lack of results, side effects, and life changes each call for a different clinical response. Side effects such as nausea, vomiting, or gastroparesis symptoms warrant a conversation with a physician before stopping the drug, not a cancellation form [11].

Cost Comparison: Calibrate vs. Alternatives

Understanding the cost structure helps you make a more informed decision.

| Option | Approximate Annual Cost | GLP-1 Included | Physician Access | |---|---|---|---| | Calibrate full program | $1,500 to $2,000 (program fee only) | Coordinated, not included | Yes | | Wegovy retail (no insurance) | $13,000 to $16,000 per year | Yes | Not included | | Wegovy with insurance | Variable; typically $0 to $300/month copay | Yes | Not included | | HealthRX GLP-1 program | Contact for current pricing | Coordinated | Yes | | Primary care GLP-1 prescribing | $150 to $300 per visit, variable | Not included | Yes |

Calibrate's program fee does not cover the cost of the medication itself. That cost is billed separately through pharmacy or insurance. If you are canceling because of medication cost, canceling Calibrate alone may not solve the problem.

What GLP-1 Discontinuation Does to the Body: A Closer Look

Weight regain is the most visible consequence of stopping a GLP-1. It is not the only one.

Appetite Hormones Rebound

GLP-1 receptor agonists reduce ghrelin secretion and increase satiety signaling. A 2022 study published in Obesity (N=96) found that ghrelin levels rose significantly within 4 weeks of semaglutide discontinuation, returning toward pre-treatment baseline by week 8 [12]. Hunger returns before the weight does, which is why patients often feel like they are "back to square one" within days of stopping.

Insulin Sensitivity May Decline

Semaglutide improves insulin sensitivity partly through weight loss and partly through direct pancreatic beta-cell effects. The American Diabetes Association's Standards of Medical Care in Diabetes, 2024 edition, recommends GLP-1 receptor agonists as first-line agents for patients with type 2 diabetes and either established cardiovascular disease or high cardiovascular risk [13]. Stopping the medication in these patients without an alternative agent risks glycemic deterioration.

Liver Fat May Increase

Non-alcoholic fatty liver disease (NAFLD) often improves on semaglutide. A 2021 randomized controlled trial published in the New England Journal of Medicine (N=320) showed that semaglutide 0.4 mg daily reduced liver fat content and improved liver histology scores in patients with NASH [14]. Liver fat can re-accumulate after discontinuation, particularly if caloric intake returns to pre-treatment levels.

Patient Rights and Billing Disputes

If you feel Calibrate has billed you incorrectly or outside the terms of your agreement, you have several remedies.

Your state attorney general's consumer protection office handles disputes with healthcare subscription companies. The Federal Trade Commission accepts complaints about unfair billing practices at ftc.gov. Most states require that subscription services provide a clear cancellation mechanism under their respective auto-renewal laws. California's Automatic Renewal Law (Business and Professions Code Section 17600) is one of the most protective in the country and applies to California residents regardless of where the company is headquartered.

Document every interaction: dates, names of representatives, and the substance of each conversation. Written records are the foundation of any successful dispute.